ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 837,37
-0,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Wave Life Sciences Ltd (WVE)

  7. Wave Life Sciences Ltd (WVE) Actualités

WVE Wave Life Sciences Ltd

6,14
0,26 (4,42%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Wave Life Sciences Ltd WVE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,26 4,42% 6,14 06:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,93 5,90 6,3799 6,14 5,88
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:30GLOBEWave Life Sciences First Quarter 2024 Financial Results..
30/4/202414:30GLOBEWave Life Sciences Announces Approval of First Clinical..
23/4/202414:30GLOBEWave Life Sciences Announces Continued Momentum in GSK..
27/3/202413:30GLOBEWave Life Sciences to Present at Upcoming Investor..
06/3/202413:55EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:39EDGAR2Form 8-K - Current report
06/3/202413:30GLOBEWave Life Sciences Reports Fourth Quarter and Full Year 2023..
28/2/202414:30GLOBEWave Life Sciences Fourth Quarter and Full Year 2023..
27/2/202414:30GLOBEWave Life Sciences Announces Upcoming Presentations at MDA..
12/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:11EDGAR2Form 8-K - Current report
08/1/202414:00GLOBEWave Life Sciences Highlights Recent Achievements and..
04/1/202422:07EDGAR2Form 8-K - Current report
03/1/202414:30GLOBEWave Life Sciences to Present at 42nd Annual J.P. Morgan..
15/12/202314:36EDGAR2Form 8-K - Current report
15/12/202314:30GLOBEWave Life Sciences Announces Initiation of Dosing in Phase 2..
08/12/202312:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/12/202303:26EDGAR2Form 8-K - Current report
07/12/202313:00GLOBEWave Life Sciences Prices $100 Million Public Offering of..
06/12/202322:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:10GLOBEWave Life Sciences Announces Proposed Public Offering of..
06/12/202322:08GLOBEWave Life Sciences Announces Initiation of Dosing in..
22/11/202314:30GLOBEWave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI..
09/11/202322:27EDGAR2Form 8-K - Current report
09/11/202314:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202314:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202313:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:39EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEWave Life Sciences Reports Third Quarter 2023 Financial..
03/11/202321:05GLOBEWave Life Sciences Third Quarter 2023 Financial Results..
02/10/202313:31EDGAR2Form 8-K - Current report
28/9/202322:15GLOBEWave Life Sciences Highlights Growth Strategy for Building..
25/9/202314:30GLOBEWave Life Sciences to Present at the Chardan 7th Annual..
06/9/202314:30GLOBEWave Life Sciences to Present at the H.C. Wainwright 25th..
05/9/202322:05EDGAR2Form 8-K - Current report
05/9/202313:30GLOBEWave Life Sciences Announces Submission of First Clinical..
24/8/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:55EDGAR2Form 144 - Report of proposed sale of securities
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202323:01EDGAR2Form 8-K - Current report
03/8/202313:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:37EDGAR2Form 8-K - Current report
03/8/202313:30GLOBEWave Life Sciences Reports Second Quarter 2023 Financial..
27/7/202314:30GLOBEWave Life Sciences Second Quarter 2023 Financial Results..

Dernières Valeurs Consultées

NASDAQ
WVE
Wave Life Sciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés